Inventor · disambiguated record
Shibin Zhou
Also filed as: ZHOU SHIBIN
14 granted patents·19 pending applications·18 citations·filing 1998–2025
88Inventor score
Files withUNIV JOHNS HOPKINS24BIOMED VALLEY DISCOVERIES INC4POMPER MARTIN G2CHEONG IAN1VOGELSTEIN BERT1
Top patents by PatentIndex Score
33 records- 0192US10869926B2Suppression of myeloid derived suppressor cells and immune checkpoint blockadeUNIV JOHNS HOPKINS·Filed 2015·Granted Dec 22, 2020·9 cites·4 claims
- 0279US8273326B2Imaging infection with compounds that bind to thymidine kinasePOMPER MARTIN G·Filed 2005·Granted Sep 25, 2012·1 cites·21 claims
- 0377US10617723B2C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Apr 14, 2020·1 cites·45 claims
- 0476US11807662B2MANAbodies and methods of usingUNIV JOHNS HOPKINS·Filed 2018·Granted Nov 7, 2023·1 cites·15 claims
- 0576US8691186B2Imaging infection with compounds that bind to thymidine kinasePOMPER MARTIN G·Filed 2012·Granted Apr 8, 2014·1 cites·8 claims
- 0676US8444963B2Tumor specific delivery of therapeutic agents via liposomaseCHEONG IAN·Filed 2007·Granted May 21, 2013·1 cites·51 claims
- 0774US2022378852A1C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2022·Application pending·0 cites
- 0873US2025381235A1Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-ctla-4 and/or anti-pd-1 antibodies to treat solid tumor malignanciesUNIV JOHNS HOPKINS·Filed 2025·Application pending·0 cites
- 0971US2015306184A1Tumor-Specific Delivery of Therapeutic Agents via Liposomase/USUNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 1071US2024166751A1Hla-restricted epitopes encoded by somatically mutated genesUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1170US11439669B2C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Sep 13, 2022·0 cites·45 claims
- 1268US12433920B2C. novyi for the treatment of solid tumors in non-human animalsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Oct 7, 2025·0 cites·39 claims
- 1368US2024294648A1MANAbodies AND METHODS OF USINGUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1467US11628204B2Preventing cytokine release syndromeUNIV JOHNS HOPKINS·Filed 2018·Granted Apr 18, 2023·0 cites·15 claims
- 1560US8901100B2Tumor-specific delivery of therapeutic agents via liposomaseUNIV JOHNS HOPKINS·Filed 2013·Granted Dec 2, 2014·0 cites·22 claims
- 1660US2019328665A1Liposome compositions encapsulating modified cyclodextrin complexes and uses thereofUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 1759US2021052729A1Suppression of myeloid derived suppressor cells and immune checkpoint blockadeUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1858US8568708B2Tumor-specific delivery of therapeutic agents via liposomaseUNIV JOHNS HOPKINS·Filed 2012·Granted Oct 29, 2013·0 cites·18 claims
- 1958US2025034252A1Manabodies targeting p53 tumor antigens and methods of usingUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2057US2024165155A1Methods and materials for targeting tumor antigensUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2156US2024124608A1Methods and materials for treating clonal t cell expansionsUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2254US12427173B2Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignanciesUNIV JOHNS HOPKINS·Filed 2015·Granted Sep 30, 2025·0 cites·10 claims
- 2353US2006281078A1Human fast-1 geneZHOU SHIBIN·Filed 2001·Application pending·0 cites
- 2453US2023338297A1Encapsulated Agents that Bind to MCT-1UNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2553US2024148870A1Engineered immune cells and uses thereofUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 2651US6110738AHuman fast-1 geneUNIV JOHNS HOPKINS·Filed 1998·Granted Aug 29, 2000·4 cites·12 claims
- 2751US2024002541A1Methods and materials for treating t cell cancersUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2849US2018161274A1Liposome Compositions Encapsulating Modified Cyclodextrin Complexes and Uses ThereofUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 2947US6225441B1Human fast-1 proteinUNIV JOHNS HOPKINS·Filed 2000·Granted May 1, 2001·0 cites·10 claims
- 3047US2023051847A1MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USINGUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 3145US2013323167A1Detecting and treating solid tumors through selective disruption of tumor vasculatureVOGELSTEIN BERT·Filed 2011·Application pending·0 cites
- 3243US2020237923A1Protein bioconjugation methodUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 3340US2018086832A1Hla-restricted epitopes encoded by somatically mutated genesUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shibin Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →